Kontigo Care AB (SE:KONT)
:KONT
Top Page
Kontigo Care AB
(KONT)
Select Model
Select Model
Rating:52Neutral
Price Target:
kr2.00
▲(11.11% Upside)
Action:ReiteratedDate:11/28/25
Kontigo Care AB's overall stock score is primarily impacted by its financial performance, which is challenged by declining revenue growth and negative profitability. Technical analysis provides a slightly positive outlook, but valuation concerns due to a negative P/E ratio and lack of dividend yield weigh heavily on the score.
Positive Factors
High gross profit margin
Kontigo's reported gross profit margin above 100% indicates its core products and services have very low direct costs relative to revenues. That structural margin supports scalable unit economics, funds product development and customer support, and provides a durable buffer against pricing pressure.
Negative Factors
Steep revenue decline
A TTM revenue decline of -55.7% signals a severe loss of top-line momentum. Such a structural drop reduces scale economics, weakens pricing power and customer reach, and makes fixed-cost absorption harder, jeopardizing long-term margin recovery and investment capacity.
Read all positive and negative factors
Positive Factors
Negative Factors
High gross profit margin
Kontigo's reported gross profit margin above 100% indicates its core products and services have very low direct costs relative to revenues. That structural margin supports scalable unit economics, funds product development and customer support, and provides a durable buffer against pricing pressure.
Read all positive factors
Kontigo Care AB (KONT) vs. iShares MSCI Sweden ETF (EWD)
Market Cap
kr57.28M
Dividend YieldN/A
Average Volume (3M)60.53K
Price to Earnings (P/E)―
Beta (1Y)-0.07
Revenue Growth-3.31%
EPS Growth-240.00%
CountrySE
Employees12
SectorHealthcare
Sector Strength45
IndustryMedical - Healthcare Information Services
Share Statistics
EPS (TTM)-0.04
Shares Outstanding35,251,427
10 Day Avg. Volume76,444
30 Day Avg. Volume60,530
Financial Highlights & Ratios
PEG Ratio0.54
Price to Book (P/B)1.50
Price to Sales (P/S)2.60
P/FCF Ratio-14.03
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)kr43.20M
Kontigo Care AB Business Overview & Revenue Model
Company Description
Kontigo Care AB (publ) provides health care solutions for addiction treatment in Sweden. It offers Previct Alcohol, a digital medical device for the treatment of alcohol dependence; and Previct Gambling, a digital tool for the treatment of gamblin...
How the Company Makes Money
Kontigo Care generates revenue through multiple channels, primarily by offering subscription-based access to its digital health platform for healthcare providers and institutions. These subscriptions typically include features such as patient mana...
Kontigo Care AB Financial Statement Overview
Summary
Income Statement
45
Neutral
Balance Sheet
60
Neutral
Cash Flow
50
Neutral
| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 29.11M | 30.24M | 28.95M | 28.43M | 24.54M | 20.38M |
| Gross Profit | 38.70M | 40.08M | 43.73M | 28.24M | 24.16M | 20.01M |
| EBITDA | 4.23M | 5.07M | 1.79M | 4.13M | 90.88K | 2.20M |
| Net Income | -1.42M | 775.00K | 212.00K | 2.90M | -1.20M | -1.28M |
Balance Sheet | ||||||
| Total Assets | 64.84M | 67.74M | 49.77M | 31.39M | 29.20M | 24.46M |
| Cash, Cash Equivalents and Short-Term Investments | 15.65M | 21.86M | 9.85M | 5.74M | 8.48M | 4.94M |
| Total Debt | 1.75M | 3.67M | 5.95M | 0.00 | 1.08K | 539.82K |
| Total Liabilities | 13.13M | 15.42M | 19.05M | 9.98M | 10.74M | 9.07M |
| Stockholders Equity | 51.72M | 52.32M | 30.72M | 21.40M | 18.46M | 15.40M |
Cash Flow | ||||||
| Free Cash Flow | 1.15M | -5.61M | -9.07M | -2.20M | 272.26K | 248.43K |
| Operating Cash Flow | 5.58M | 4.61M | 5.97M | 7.30M | 4.61M | 3.99M |
| Investing Cash Flow | -10.97M | -10.70M | -16.73M | -9.50M | -4.34M | -3.74M |
| Financing Cash Flow | 7.68M | 18.11M | 14.87M | -540.00K | 3.27M | -987.76K |
Kontigo Care AB Technical Analysis
Neutral
1.80
Price Trends
1.70
Negative
1.81
Negative
1.91
Negative
Market Momentum
-0.04
Positive
47.58
Neutral
15.89
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SE:KONT, the sentiment is Neutral. The current price of 1.8 is above the 20-day moving average (MA) of 1.64, above the 50-day MA of 1.70, and below the 200-day MA of 1.91, indicating a bearish trend. The MACD of -0.04 indicates Positive momentum. The RSI at 47.58 is Neutral, neither overbought nor oversold. The STOCH value of 15.89 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Neutral sentiment for SE:KONT.
Kontigo Care AB Peers Comparison
UnderperformOutperform
Sector (51)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
52 Neutral | kr57.28M | -30.25 | -4.02% | ― | -3.31% | -240.00% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
49 Neutral | kr146.35M | -2.83 | ― | ― | -8.33% | -329.50% | |
47 Neutral | kr82.60M | -5.14 | -202.18% | ― | ― | 20.55% | |
44 Neutral | kr56.44M | -8.36 | ― | ― | ― | ― | |
43 Neutral | kr137.46M | -1.96 | ― | ― | ― | ― | |
41 Neutral | kr25.57M | -5.72 | 209.66% | ― | 10.03% | 66.78% |
* Healthcare Sector Average
SE:KONT
Kontigo Care AB
1.63
-0.46
-21.88%
SE:AINO
Aino Health AB
0.13
-0.07
-34.21%
SE:ONCOZ
OncoZenge AB
5.88
0.48
8.89%
SE:HEART
Scandinavian Real Heart AB
13.75
0.80
6.15%
SE:SDOS
ScandiDos AB
0.99
-0.27
-21.43%
SE:PTRK
Physitrack Limited
9.00
-2.45
-21.40%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.